chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by a pharmacist via call center representative and described the occurrence of injection site redness in an unspecified number of patients who received FLUARIX quadrivalent (batch umber 3L9LD, expiry date 30th June 2016). In 2015, the patients received FLUARIX quadrivalent. On an unknown date, an unknown time after receiving FLUARIX quadrivalent, the patients experienced injection site redness, injection site swelling, injection site pain, injection site warmth and pharmaceutical product complaint. On an unknown date, the outcome of the injection site redness, injection site swelling, injection site pain, injection site warmth and pharmaceutical product complaint were unknown. It was unknown if the reporter considered the injection site redness, injection site swelling, injection site pain and injection site warmth to be related to FLUARIX quadrivalent. Additional details were received as follows: In 2015, about 60 percent of the patients who received FLUARIX quadrivalent, experienced redness, swelling, pain and heat warmth at the injection site. The reporter stated that, they had used FLUARIX quadrivalent last year but did not experience any adverse events. The reporter had called to ask whether there were any changes in the formulation of FLUARIX quadrivalent this year and regarding the frequency of occurrence of the events after FLUARIX quadrivalent this year. This case was associated with product complaint. No further information was available regarding events.
I was having an issue with numbness in my right ear. I went to the hospital on January 26, 2023, for it, and they did a whole battery of test, and they could not find anything. In addition, I have been dealing with some shortness of breath in the last month or 2. I had a Pulmonary Function Test, and the results show FRC decreased, and SBC reduced. No medication has been prescribed yet, but an inhaler has been suggested. We have also looked into anxiety as I am now being treated for it, but those symptoms started after my 2nd dose of the vaccine. My symptoms have improved since starting the medication.
Fever of over 101.0 almost every day since vaccine, joint pain, body aches, chills, severe headache, swollen lymph nodes in neck. All symptoms everyday. One day did not have fever because Tylenol was taken consistently, but as soon as medication wore off the fever returned. Tylenol and ibuprofen taken to help alleviate symptoms. Had Covid test on 11/25 and was negative. I was seen by PCP on 11/29 and had another Covid test and some labs drawn. Awaiting results. Still sick with fever.
Brain fog, short-term memory loss, rapid and irregular heartbeat, shortness of breath, fatigue lasting for several months
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) at the age of 44 years for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: METFORMIN. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. Additional information: other medication in 2weeks: Yes, anti viral details ,product: COVID 19 Treatment, brand: Paxlovid, covid vaccine details ,vaccine brand: Other, vaccine brand other: Moderna, previous 3x were Pfizer, other medication details, other medication in 2weeks product: Metformin. Adverse event: Rebound infection 2plus weeks after taking Paxlovid.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Received 12 month immunizations on 3-5-07. Had facial rash that evening. Had fever a few days later on 3-25-07 began to have petechiae. On 3-26-07 had more bruising, petechiae on face, trunk, genital area. Received IVIG with no response.  Discharged on prednisone on 4-2-07 plts 25,000.  4/17/07 Received medical records from hospital which reveal patient experienced facial rash, fever, emesis, mucus stools since vax, facial petechiae which spread to chest, trunk & legs.  Seen in PCP office on day of admit & plt count was reported as 7,000.  On day of admission 3/26, patients mother was treated for strep throat.  Admitted 3/26/07-4/2/07.  No d/c summary with records received.  Tx w/IVIG.  Platelets increased but remained well below normal at D/C to home w/close f/u & tapering steroids. FINAL DX: Thrombocytopenia, possibly vaccine related, viral or idiopathic.
She said stomach spasm, diarrhea, nausea, chills and very weak.
This spontaneous report was received from a registered nurse refers to an unknown number of patients of unknown age and gender. On an unknown date the patients were vaccinated with an improperly stored dose of PROQUAD (Merck) (dose, lot # and route of administration were not reported). No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
Vaccine (PREVNAR 13) administered 12/31/14 and she developed rash, itching 1/1/15. She took medication (BENADRYL) for symptom relief. Called the clinic on 1/9/15. Visit with doctor on 1/12/15. Provider encourage BENADRYL.
Patient received COVID19 booster in right arm, annual flu shot in left arm.  Has received flu vaccine annually since birth.  About 2 hours after administration, developed itchy, red rash over body.  Said her lips, mouth, and throat felt "funny".  No shortness of breathing.  Benadryl 25mg administered at 1230p.  Pediatrician notified and recommended evaluation at urgent care.  Went to urgent care, vitals all fine.  Symptoms continued to improve, no additional treatment needed.
This spontaneous report as received from a physician refers to a patient of unknown age and gender. On 04-MAY-2015, the patient was vaccinated with improperly stored PNEUMOVAX (lot # K024976 exp date 09-JUN-2016) (dose and route not reported). The temperature and time of excursion was 1.11 degrees C for 64 hours. The vaccine status was reported as "in excursion", the storage criteria and the vaccine excursion were reported as "Refrigerator (R)". No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Patient received Pfizer COVID vaccine first 2 doses (3/2/21 lot # EN6200 and 3/31/21 lot # ER8737). While in  state, patient received the third Pfizer COVID vaccine dose on 12/23/21. On 12/29/21, patient admitted to our inpatient facility with acute respiratory failure with hypoxia due to COVID pneumonia. Patient most likely got COVID during her immunocompromised state while on 18-day prednisone taper started on 12/10/21 for atopic dermatitis.  As of today (1/4/22), patient is still admitted in our med/surg unit.
At 5:02pm next day I was outcome with dizziness, couldn't walk couldn't move. My husband carried me to bed. So dizzy that I vomited twice within the next 2 hours. Couldn't turned my head while laying down because the room would spin with blurry vision. Next day would up with migraine. Since the vaccine I've woken up with migraine on multiple days and feel fatigue. And coughing up mucus...like when I an infection in my lungs.
SORE ARM; It was not as mobile as it is normally; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 51-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In January 2020, the patient received the 1st dose of Shingrix. On an unknown date, between 4 and 6 months after receiving Shingrix, the patient experienced pain in arm and movements reduced. On an unknown date, the outcome of the pain in arm was not recovered/not resolved and the outcome of the movements reduced was unknown.   It was unknown if the reporter considered the pain in arm and movements reduced to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The patient had her first dose in January and experienced a sore arm for about a week. It was not as mobile as it was normally. The reporter consent to follow up. For tolerance after 2nd dose of Shingrix, refer case US2020AMR107469.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR107469:same patient
This spontaneous report was received from a registered nurse and refers to multiple patients of an unknown gender and age. The patients' concurrent conditions, medical history and concomitant therapy were not reported. On unknown dates, the patients were vaccinated with an unspecified number of doses of improperly stored RECOMBIVAX HB 0.5microgram/0.5ml, lot # L018501, expiration date: 22-JUN-2017 (dose and route of administration were not reported). There were no adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
Dose given was the 21st dose taken from the vial. No adverse effect has been noted.
Woke up at 8 am drank some orange juice and immediately threw up several times and began having hot flashes for a couple hours.  By 10 am ,  she seemed to settle enough to try and drink some slim fast.  She feels weak and tired.
Patient felt hot and dizzy and had syncopal episode and vital signs BP 122/68, PR-86, SPO2-97. Blood glucose-129. EMS called and patient transported to hospital.
Continued alternating chills/fever through Sunday morning.; Muscle aches Saturday thru Sunday, but began to improve mid-day Sunday.; By 3:00pm shivering with cold and went to bed. Continued alternating chills/fever through Sunday morning.; 4/23 Friday- Diarrhea all day, but otherwise ok until after noon.; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 15Apr2021 at 10:30 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 25Mar2021 at 14:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. On 23Apr2021 at 07:00, Friday, the patient experienced diarrhea all day, but otherwise okay until that afternoon. On 23Apr2021 by 15:00, the patient experienced shivering with cold and went to bed. It continued with alternating chills and fever through Sunday morning. On 24Apr2021, Saturday, the patient experienced muscle aches, which began to improve in the mid-day of Sunday. On 25Apr2021, Sunday, the patient experienced fever. The patient had slept most of the weekend and was on fluids. By Monday morning, all symptoms were gone. The patient could find no report of reaction a full week after second dose. The patient reported that she worked remotely and followed safety guidelines on the rare occasions when left home. The patient was seldom sick at any time, and she didn't even have a cold, much less any other illness in over a year of heightened precautions. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event diarrhea was resolved on 23Apr2021; while that of shivering or chills, muscle aches and fever was resolved on 26Apr2021.  No follow-up attempts are needed. No further information is expected.
Information has been received from a LPN concerning a 7 year old female birth twin with a penicillin allergy and no other pertinent medical history who on 25Apr02 was vaccinated with a dose of varicella virus vaccine live. There was no concomitant medication. In approx Apr 2004 the pt experienced break through chickenpox. She was exposed to her unvaccinated sibling and he had a bad case of natural varicella around that time. The pt was afebrile and had approx 10 lesions sporadically over her body. Unspecified medical attention was sought and no treatment was required. No diagnostic lab studies were performed. The pt was noted to be recovering with sequelae. A product quality complaint was not involved. Additional information has been requested. The LPN also reported that the pt's twin had a similar experience after therapy with varicella virus vaccine live (lot 0404USA01741) as well as an increase in breakthrough varicella after therapy with varicella virus vaccine live (lot 0404USA01852).
Rash on the feet and lower legs; Small dark red spots, not itchy. Appeared this morning, day 3; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the right arm on 08Apr2021 at 16:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. The patient's medical history was not reported. Concomitant medication included escitalopram oxalate (LEXAPRO). The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 11Apr2021 at 11:00, the patient experienced rash on the feet and lower legs and small dark red spots, not itchy. The patient reported that this rash on feet and lower legs and small red spots appeared in morning of day 3. The events did not result in doctor/other health care professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event rash on the feet and lower legs, small dark red spots, not itchy was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
got gillian barre; This case was reported by a consumer via interactive digital media and described the occurrence of guillain barre syndrome in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced guillain barre syndrome (serious criteria GSK medically significant). On an unknown date, the outcome of the guillain barre syndrome was unknown.   The reporter considered the guillain barre syndrome to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient's wife. The age at vaccination was not reported. The reporter's husband got Guillain barre from shingle shot be careful. No contact details were available.
Excruciating abdominal pain, left arm pain, chest pain.  Gangrenous appendicitis requiring emergency surgery and followed by admission for complicated acute abdomen.
Naused, sweating, dizzy, numbness in hands & feet a few minutes post vaccine administration
chins feeling burning hot; itchy, sore at the injection site, warm touch; chills; itchy, sore at the injection site, warm touch; itchy, sore at the injection site, warm touch; extremely fatigued; heaviness in the chest; muscle tightness; red chic down the chin; pain in the neck; Itchiness at the injection site; nausea; muscle pain; headache; diarrhea; sore arm; crummy dizziness; Chills; felt hot; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (felt hot), FEELING HOT (chins feeling burning hot), CHEST DISCOMFORT (heaviness in the chest), DIARRHOEA (diarrhea) and MUSCLE TIGHTNESS (muscle tightness) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced FEELING HOT (felt hot), PAIN IN EXTREMITY (sore arm), DIZZINESS (crummy dizziness) and CHILLS (Chills). On 19-Jan-2021, the patient experienced DIARRHOEA (diarrhea) and HEADACHE (headache). On 20-Jan-2021, the patient experienced MUSCLE TIGHTNESS (muscle tightness), ERYTHEMA (red chic down the chin), NECK PAIN (pain in the neck), VACCINATION SITE PRURITUS (Itchiness at the injection site), NAUSEA (nausea) and MYALGIA (muscle pain). On 22-Jan-2021, the patient experienced CHEST DISCOMFORT (heaviness in the chest) and FATIGUE (extremely fatigued). On 26-Jan-2021, the patient experienced FEELING HOT (chins feeling burning hot), VACCINATION SITE WARMTH (itchy, sore at the injection site, warm touch), CHILLS (chills), INJECTION SITE PRURITUS (itchy, sore at the injection site, warm touch) and INJECTION SITE PAIN (itchy, sore at the injection site, warm touch). At the time of the report, FEELING HOT (felt hot), FEELING HOT (chins feeling burning hot), CHEST DISCOMFORT (heaviness in the chest), DIARRHOEA (diarrhea), MUSCLE TIGHTNESS (muscle tightness), ERYTHEMA (red chic down the chin), NECK PAIN (pain in the neck), VACCINATION SITE WARMTH (itchy, sore at the injection site, warm touch), VACCINATION SITE PRURITUS (Itchiness at the injection site), PAIN IN EXTREMITY (sore arm), DIZZINESS (crummy dizziness), CHILLS (Chills), HEADACHE (headache), CHILLS (chills), NAUSEA (nausea), MYALGIA (muscle pain), FATIGUE (extremely fatigued), INJECTION SITE PRURITUS (itchy, sore at the injection site, warm touch) and INJECTION SITE PAIN (itchy, sore at the injection site, warm touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported. No treatment information was reported
Immediately after vaccine had shooting pain in left arm, within an hour pt c/o pain in both legs that felt like pressure pain becoming shooting pain into lower leg and foot.  Pt told to rest and given ibuprofen, pain resolved w/in 2-3 hrs.  Some dizziness.  No fainting.
Information has been received from a nurse referring to an unknown number of patients of unknown age and gender. No relevant medical history or concurrent conditions were reported. On unknown dates, these patients were vaccinated with improperly stored RECOMBIVAX HB (lot # L044694, expiration date 04-FEB-2018; dose, route and dose number were not reported; temperature/time frame: 49.1 Fahrenheit/4 hours and 30 minutes; therapy type: Digital Data Logger; previous temperature excursion: 65.2 Fahrenheit for 8 hours and 15 minutes). No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
vaccine administration error regarding Pfizer lot # GJ5342  administered on 05/30/2023 with beyond use date of 01/18/2023 with recommendation to get booster at local pharmacy
Sore arm at injection site, low grade fever (100.5), body aches, nausea, headache, vomit 1x. Used Tylenol and Advil. Most severe first night,  starting about 6 hours post vaccination and continuing through night into the next morning/afternoon. I was able to resume activities 27 hours post vaccine.
7 pm (about 7 hours after vaccine), very nauseated, dry heaving a few times, pounding headache, legs below knees had sharp shooting pains, nearly uncontrolable shivering, severe arm pain from injection.  Took Ibuprofen, rubbed "cramp cream" on legs, used heating pad under multiple blankets to keep warm.  Had trouble sleeping because of the throbbing, but woke up with a headache and some arm pain. Feeling a lot better on day 2.
Injection site pain; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Jun2021 at 08:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any other medications within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 01Jun2021, the patient experienced injection site pain. Therapeutic measures were not taken as a result of the event. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event injection site pain was not recovered at the time of this report.   Information on lot/batch number has been requested.
I already have mild tinnitus from my Menieres disease. It was quiet and would happen randomly but after receiving the 2nd Moderna shot, the tinnitus was much louder and is now constant.
Patient given ZOSTAVAX. After injection, it was discovered that patient was receiving BCG for Bladder Cancer. Patient is under ongoing monitoring and had not had any adverse reactions.
Pain, redness and swelling to Lt. deltoid. Mother notes sx started after shots were given. Sx have gotten a little better. Rx for PRELONE 15mg/5ml and BENADRYL.
Pt. would not walk on (R) leg, c/o severe pain no physical abnormality seen. Improved in 48 hrs.
Initial report was received from a health care professional on 26 September 2011. A 49 year-old female patient with a history of scleroderma had received on an unspecified date in 2011 an intramuscular right deltoid injection of FLUZONE No Preservative 2011-2012, lot number UH442AB (reported as possibly) and an unspecified amount of time later experienced a "limp" arm. Concomitant medication included NORVASC, omeprazole, SYMBALTA, quinidine, atropine and Enalapril. No further information was available at the time of the report. The patient's outcome was not recovered. Documents held by sender: none.